Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
4DMedical Ltd ( (AU:4DX) ) has shared an announcement.
4DMedical Ltd has announced the quotation of 4,166,698 ordinary fully paid securities on the Australian Securities Exchange (ASX) under the code 4DX. This move is part of the company’s strategic efforts to leverage convertible securities, potentially enhancing its financial flexibility and market presence.
The most recent analyst rating on (AU:4DX) stock is a Buy with a A$1.05 price target. To see the full list of analyst forecasts on 4DMedical Ltd stock, see the AU:4DX Stock Forecast page.
More about 4DMedical Ltd
4DMedical Ltd is a company operating in the medical technology industry, primarily focusing on developing advanced imaging solutions. The company is known for its innovative products that enhance the diagnosis and management of respiratory diseases, aiming to improve patient outcomes and healthcare efficiency.
Average Trading Volume: 5,374,644
Technical Sentiment Signal: Buy
Current Market Cap: A$871.1M
Find detailed analytics on 4DX stock on TipRanks’ Stock Analysis page.